Ana səhifə

Present position and address


Yüklə 485 Kb.
səhifə3/4
tarix26.06.2016
ölçüsü485 Kb.
1   2   3   4

Wijns W.

Int J Cardiovasc Imaging. 2004 Dec;20(6):529-30. No abstract available.


Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.

Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W; European Society of Cardiology.

Eur Heart J. 2005 Jun;26(12):1169-79. Epub 2005 Mar 31.
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W; Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Eur Heart J. 2005 Apr;26(8):804-47. Epub 2005 Mar 15.
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, Constantini CR, Guermonprez JL, Eltchaninoff H, Blanchard D, Bartorelli A, Laarman GJ, Perin M, Sousa JE, Schuler G, Molnar F, Guagliumi G, Colombo A, Ban Hayashi E, Wülfert E.

Circulation. 2005 Mar 1;111(8):1040-4. Epub 2005 Feb 21.


Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?

Gruberg L, Mercado N, Milo S, Boersma E, Disco C, van Es GA, Lemos PA, Ben Tzvi M, Wijns W, Unger F, Beyar R, Serruys PW; Arterial Revascularization Therapies Study Investigators.

Am J Cardiol. 2005 Feb 15;95(4):439-44.
Pressure-derived measurement of coronary flow reserve.

MacCarthy P, Berger A, Manoharan G, Bartunek J, Barbato E, Wijns W, Heyndrickx GR, Pijls NH, De Bruyne B.

J Am Coll Cardiol. 2005 Jan 18;45(2):216-20.
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.

Barbato E, Piscione F, Bartunek J, Galasso G, Cirillo P, De Luca G, Iaccarino G, De Bruyne B, Chiariello M, Wijns W.

Circulation. 2005 Jan 25;111(3):288-94. Epub 2005 Jan 10.
Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent: a post hoc subanalysis of the pooled E- and C-SIRIUS trials.

Schlüter M, Schofer J, Gershlick AH, Schampaert E, Wijns W, Breithardt G; E- and C-SIRIUS Investigators.

J Am Coll Cardiol. 2005 Jan 4;45(1):10-3.
Association of plaque characterization by intravascular ultrasound virtual histology and arterial remodeling.

Fujii K, Carlier SG, Mintz GS, Wijns W, Colombo A, Böse D, Erbel R, de Ribamar Costa J Jr, Kimura M, Sano K, Costa RA, Lui J, Stone GW, Moses JW, Leon MB.

Am J Cardiol. 2005 Dec 1;96(11):1476-83. Epub 2005 Oct 12.
Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.

Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Koglin J, Russell ME; TAXUS VI Investigators.

Circulation. 2005 Nov 22;112(21):3306-13. Epub 2005 Nov 14.
Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial.

Ribichini F, Ferrero V, Piessens M, Heyndrickx GR, de Bruyne B, Verbeke L, Matullo G, Büchi M, Piazza A, Guarrera S, Lüscher TF, Wijns W.

Cardiovasc Revasc Med. 2005 Jan-Mar;6(1):7-13.
[Current concepts of the physiopathology of coronary beta-adrenergic receptors, and their clinical applications]

Barbato E, Wijns W, De Bruyne B, Mascia G, Piscione F.

Recenti Prog Med. 2005 Sep;96(9):411-5. Review. Italian.
Hyperdynamic myocardial response to beta-adrenergic stimulation in patients with chest pain and normal coronary arteries.

Madaric J, Bartunek J, Verhamme K, Penicka M, Van Schuerbeeck E, Nellens P, Heyndrickx GR, Wijns W, Vanderheyden M, De Bruyne B.

J Am Coll Cardiol. 2005 Oct 4;46(7):1270-5.
[Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC.]

Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyłło W, Urban P, Stone GW, Wijns W; European Society of Cardiology.

Kardiol Pol. 2005 Sep;63(3):265-320; discussion 321-3. Review. Polish. No abstract available.
Hybrid revascularization strategy: a pilot study on the association of robotically enhanced minimally invasive direct coronary artery bypass surgery and fractional-flow-reserve-guided percutaneous coronary intervention.

Davidavicius G, Van Praet F, Mansour S, Casselman F, Bartunek J, Degrieck I, Wellens F, De Geest R, Vanermen H, Wijns W, De Bruyne B.

Circulation. 2005 Aug 30;112(9 Suppl):I317-22.
Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.

Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, Van Haute I, Lootens N, Heyndrickx G, Wijns W.

Circulation. 2005 Aug 30;112(9 Suppl):I178-83.
The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.

Lefèvre T, Ormiston J, Guagliumi G, Schultheiss HP, Quilliet L, Reimers B, Brunel P, Wijns W, Buettner HJ, Hartmann F, Veldhof S, Miquel K, Su X, van der Giessen WJ.

J Am Coll Cardiol. 2005 Aug 16;46(4):592-8.
[Guidelines for percutaneous coronary interventions]

Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W; Task Force per le Procedure Coronariche Percutanee della Società Europea di Cardiologia.

Ital Heart J Suppl. 2005 Jul;6(7):427-74. Review. Italian. No abstract available.

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.

Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):512-9.
Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease.

Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, Heyndrickx GR, Pijls NH, De Bruyne B.

J Am Coll Cardiol. 2005 Aug 2;46(3):438-42.
Cardiac imaging in coronary artery disease: differing modalities.

Schuijf JD, Shaw LJ, Wijns W, Lamb HJ, Poldermans D, de Roos A, van der Wall EE, Bax JJ.

Heart. 2005 Aug;91(8):1110-7. Review. No abstract available.
[Guidelines for percutaneous coronary interventions]

Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C, Jørgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W; Grupo de Trabajo de la Sociedad Europea de Cardiologia de intervención coronaria percutánia.

Rev Esp Cardiol. 2005 Jun;58(6):679-728. Spanish. No abstract available.
The diagnosis of coronary artery disease: in search of a "one-stop shop"?

Wijns W.

J Nucl Med. 2005 Jun;46(6):904-5. No abstract available.


Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial.

Wijns W, Verheye S, Manoharan G, Werner GS, Grube E, De Bruyne B, Koolen J, Hamm CW, Medina A, Bech JW, De Feyter PJ; CONVERTIBLE investigators.

Eur Heart J. 2005 Sep;26(18):1852-9. Epub 2005 May 11.


Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).

Ix JH, Mercado N, Shlipak MG, Lemos PA, Boersma E, Lindeboom W, O'Neill WW, Wijns W, Serruys PW.

Am Heart J. 2005 Mar;149(3):512-9.
Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease.

Breeman A, Bertrand ME, Ottervanger JP, Hoeks S, Lenzen M, Sechtem U, Legrand V, de Boer MJ, Wijns W, Boersma E.

Diabetes Care. 2006 Sep;29(9):2003-11.
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE; ENDEAVOR II Investigators.

Circulation. 2006 Aug 22;114(8):798-806. Epub 2006 Aug 14.
Sirolimus-eluting stent in chronic total occlusion: the SICTO study.

Lotan C, Almagor Y, Kuiper K, Suttorp MJ, Wijns W.

J Interv Cardiol. 2006 Aug;19(4):307-12.
FX MiniRAIL catheter usage for treatment of de novo complex coronary lesions: results from the "OFFAR".

Vitrella G, Sangiorgi G, Kornowski R, Mosseri M, Almagor Y, Ischinger T, Pavlidis G, Rodermann J, Bartorelli A, Wijns W, Grube E, Colombo A; OFFAR Investigators.

J Interv Cardiol. 2006 Jun;19(3):250-7.
Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction.

Mansour S, Vanderheyden M, De Bruyne B, Vandekerckhove B, Delrue L, Van Haute I, Heyndrickx G, Carlier S, Rodriguez-Granillo G, Wijns W, Bartunek J.

J Am Coll Cardiol. 2006 Apr 18;47(8):1727-30. Epub 2006 Mar 27. No abstract available.
Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.

Ickx BE, van der Linden PJ, Melot C, Wijns W, de Pauw L, Vandestadt J, Hut F, Pradier O.

Transfusion. 2006 Apr;46(4):595-605.
The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart.

Bartunek J, Dimmeler S, Drexler H, Fernández-Avilés F, Galinanes M, Janssens S, Martin J, Mathur A, Menasche P, Priori S, Strauer B, Tendera M, Wijns W, Zeiher A; task force of the European Society of Cardiology.

Eur Heart J. 2006 Jun;27(11):1338-40. Epub 2006 Mar 16.
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.

Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, Seth A, Sousa JE, Wijns W, Berge C, Deme M, Stoll HP; e-Cypher Investigators.

Circulation. 2006 Mar 21;113(11):1434-41. Epub 2006 Mar 13.
Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary Revascularization.

Lenzen M, Scholte op Reimer W, Norekvål TM, De Geest S, Fridlund B, Heikkilä J, Jaarsma T, Mårtensson J, Moons P, Smith K, Stewart S, Strömberg A, Thompson DR, Wijns W.

Eur J Cardiovasc Nurs. 2006 Jun;5(2):115-21. Epub 2006 Mar 10.
Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction.

Bartunek J, Wijns W, Heyndrickx GR, Vanderheyden M.

Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S52-6.
Assessment of renal flow and flow reserve in humans.

Manoharan G, Pijls NH, Lameire N, Verhamme K, Heyndrickx GR, Barbato E, Wijns W, Madaric J, Tielbeele X, Bartunek J, De Bruyne B.

J Am Coll Cardiol. 2006 Feb 7;47(3):620-5. Epub 2006 Jan 18.
Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography.

Schuijf JD, Bax JJ, Shaw LJ, de Roos A, Lamb HJ, van der Wall EE, Wijns W.

Am Heart J. 2006 Feb;151(2):404-11. Review.
Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging.

Schuijf JD, Wijns W, Jukema JW, Atsma DE, de Roos A, Lamb HJ, Stokkel MP, Dibbets-Schneider P, Decramer I, De Bondt P, van der Wall EE, Vanhoenacker PK, Bax JJ.

J Am Coll Cardiol. 2006 Dec 19;48(12):2508-14. Epub 2006 Nov 28.
Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire?

Wijns WC, Krucoff MW.

Eur Heart J. 2006 Dec;27(23):2737-9. Epub 2006 Nov 15. No abstract available.


Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.

Hordijk-Trion M, Lenzen M, Wijns W, de Jaegere P, Simoons ML, Scholte op Reimer WJ, Bertrand ME, Mercado N, Boersma E; EHS-CR Investigators.

Eur Heart J. 2006 Mar;27(6):671-8. Epub 2006 Jan 19.
A comparative regional analysis of coronary atherosclerosis and calcium score on multislice CT versus myocardial perfusion on SPECT.

Schuijf JD, Wijns W, Jukema JW, Decramer I, Atsma DE, de Roos A, Stokkel MP, Dibbets-Schneider P, van der Wall EE, Bax JJ.

J Nucl Med. 2006 Nov;47(11):1749-55.
Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.

Breeman A, Hordijk-Trion M, Lenzen M, Hoeks S, Ottervanger JP, Bertrand ME, Sechtem U, Zaliunas R, Legrand V, de Boer MJ, Stahle E, Mercado N, Wijns W, Boersma E; Euro Heart Survey on Coronary Revascularization.

J Thorac Cardiovasc Surg. 2006 Nov;132(5):1001-9.
Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease.

Schuijf JD, Poldermans D, Shaw LJ, Jukema JW, Lamb HJ, de Roos A, Wijns W, van der Wall EE, Bax JJ.

Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):93-104. Review.
Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium.

Bartunek J, Croissant JD, Wijns W, Gofflot S, de Lavareille A, Vanderheyden M, Kaluzhny Y, Mazouz N, Willemsen P, Penicka M, Mathieu M, Homsy C, De Bruyne B, McEntee K, Lee IW, Heyndrickx GR.

Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1095-104. Epub 2006 Oct 20.
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation.

Lenzen MJ, Scholte op Reimer WJ, Pedersen SS, Boersma E, Maier W, Widimsky P, Simoons ML, Mercado NF, Wijns W; Euro Heart Survey on Coronary Revascularization.

Heart. 2007 Mar;93(3):339-44. Epub 2006 Sep 15.
Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).

Sakurai R, Hongo Y, Yamasaki M, Honda Y, Bonneau HN, Yock PG, Cutlip D, Popma JJ, Zimetbaum P, Fajadet J, Kuntz RE, Wijns W, Fitzgerald PJ; ENDEAVOR II Trial Investigators.

Am J Cardiol. 2007 Sep 1;100(5):818-23. Epub 2007 Jun 14.
Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease: meta-analysis.

Vanhoenacker PK, Heijenbrok-Kal MH, Van Heste R, Decramer I, Van Hoe LR, Wijns W, Hunink MG.

Radiology. 2007 Aug;244(2):419-28.
Effect of mitral valve repair on exercise tolerance in asymptomatic patients with organic mitral regurgitation.

Madaric J, Watripont P, Bartunek J, Casselman F, Vanderheyden M, Van Praet F, Wijns W, Feys A, Vanermen H, De Bruyne B.

Am Heart J. 2007 Jul;154(1):180-5.
Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy.

Barbato E, Penicka M, Delrue L, Van Durme F, De Bruyne B, Goethals M, Wijns W, Vanderheyden M, Bartunek J.

Heart. 2007 Jul;93(7):856-61.
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.

Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W.

Eur Heart J. 2007 Jul;28(13):1598-660. Epub 2007 Jun 14. No abstract available.
What does the clinical cardiologist need from noninvasive cardiac imaging: is it time to adjust practices to meet evolving demands?

Wijns W, De Bruyne B, Vanhoenacker PK.

J Nucl Cardiol. 2007 May-Jun;14(3):366-70. Review.


Multi-detector CT of the coronary arteries. Potential use of CT angiography and coronary artery calcium scoring in screening.

Vanhoenacker R, Wijns W, Sarno G.

JBR-BTR. 2007 Mar-Apr;90(2):80-3. Review. No abstract available.
Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.

Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, Bär F, Hoorntje J, Koolen J, Wijns W, de Bruyne B.

J Am Coll Cardiol. 2007 May 29;49(21):2105-11. Epub 2007 May 17.
Differences in plaque composition and distribution in stable coronary artery disease versus acute coronary syndromes; non-invasive evaluation with multi-slice computed tomography.

Schuijf JD, Beck T, Burgstahler C, Jukema JW, Dirksen MS, de Roos A, van der Wall EE, Schroeder S, Wijns W, Bax JJ.

Acute Card Care. 2007;9(1):48-53.
The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents.

Wang TY, Hasselblad V, Peterson JL, Wijns W, Parhizgar A, Kereiakes DJ, Krucoff MW.

Am Heart J. 2007 May;153(5):743-8.
The European Association of Percutaneous Cardiovascular Interventions. Interview with Dr. William Wijns by Emma Baines.

Wijns W.

Circulation. 2007 Apr 3;115(13):f57-8. No abstract available


Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation.

Stéphenne X, Vosters O, Najimi M, Beuneu C, Dung KN, Wijns W, Goldman M, Sokal EM.

Liver Transpl. 2007 Apr;13(4):599-606. Erratum in: Liver Transpl. 2007 Jul;13(7):1070.
Role of imaging in cardiac stem cell therapy.

Beeres SL, Bengel FM, Bartunek J, Atsma DE, Hill JM, Vanderheyden M, Penicka M, Schalij MJ, Wijns W, Bax JJ.

J Am Coll Cardiol. 2007 Mar 20;49(11):1137-48. Epub 2007 Mar 6. Review.
Anatomic-functional imaging by single-photon emission computed tomography/computed tomography as the cornerstone of diagnosis and treatment for coronary patients: a glimpse into the (near) future?

Wijns W.

J Am Coll Cardiol. 2007 Mar 13;49(10):1068-70. Epub 2007 Feb 26. No abstract available.


Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.

Camenzind E, Steg PG, Wijns W.

Circulation. 2007 Mar 20;115(11):1440-55; discussion 1455. Epub 2007 Mar 7. Review. No abstract available.
Intracoronary beta-irradiation for the treatment of de novo lesions: 5-year clinical follow-up of the BetAce randomized trial.

Ferrero V, Ribichini F, Piessens M, Heyndrickx GR, Verbeke L, de Bruyne B, Feola M, Vassanelli C, Wijns W.

Am Heart J. 2007 Mar;153(3):398-402.
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.

Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE; ENDEAVOR II Investigators.

Minerva Cardioangiol. 2007 Feb;55(1):1-18. English, Italian.
Bone-marrow-derived cells for cardiac stem cell therapy: safe or still under scrutiny?

Bartunek J, Vanderheyden M, Wijns W, Timmermans F, Vandekerkhove B, Villa A, Sánchez PL, Arnold R, San Román JA, Heyndrickx G, Fernandez-Aviles F.

Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S100-5.
Cold cardioplegia for acute infarction a viable adjunct to reperfusion therapy?

Wijns W, Heyndrickx GR.

J Am Coll Cardiol. 2007 Jan 16;49(2):261-2. Epub 2006 Dec 29. No abstract available.


Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization.

Penicka M, Tousek P, De Bruyne B, Wijns W, Lang O, Madaric J, Vanderheyden M, Tintera J, Malý M, Widimsky P, Bartunek J.

Eur Heart J. 2007 Jun;28(11):1366-73. Epub 2007 Jan 5.
GLU-27 variant of beta2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease.

Barbato E, Berger A, Delrue L, Van Durme F, Manoharan G, Boussy T, Heyndrickx GR, De Bruyne B, Ciampi Q, Vanderheyden M, Wijns W, Bartunek J.

Atherosclerosis. 2007 Oct;194(2):e80-6. Epub 2006 Nov 13.
Time-dependent effects on coronary remodeling and epicardial conductance after intracoronary injection of enriched hematopoietic bone marrow stem cells in patients with previous myocardial infarction.

Vanderheyden M, Vercauteren S, Mansour S, Delrue L, Vandekerckhove B, Heyndrickx GR, Van Haute I, De Bruyne B, Timmermans F, Wijns W, Bartunek J.

Cell Transplant. 2007;16(9):919-25.
Detection of non-ST-elevation myocardial infarction and unstable angina in the acute setting: meta-analysis of diagnostic performance of multi-detector computed tomographic angiography.

Vanhoenacker PK, Decramer I, Bladt O, Sarno G, Bevernage C, Wijns W.

BMC Cardiovasc Disord. 2007 Dec 19;7:39. Review.
Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.

Gershlick A, Kandzari DE, Leon MB, Wijns W, Meredith IT, Fajadet J, Popma JJ, Fitzgerald PJ, Kuntz RE; ENDEAVOR Investigators.

Am J Cardiol. 2007 Oct 22;100(8B):45M-55M. Review.
Universal definition of myocardial infarction.

Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N.

Circulation. 2007 Nov 27;116(22):2634-53. Epub 2007 Oct 19. No abstract available.
TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.

Grube E, Dawkins KD, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Buellesfeld L, Koglin J, Russell ME.

Eur Heart J. 2007 Nov;28(21):2578-82. Epub 2007 Oct 14.
Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.

Devreese K, Wijns W, Combes I, Van kerckhoven S, Hoylaerts MF.

Thromb Haemost. 2007 Sep;98(3):600-13.
Advancing the knowledge base on the efficacy-safety ratio with drug-eluting stents contributions from the European Society of Cardiology Congress, Vienna, Austria, September 1-5, 2007.

1   2   3   4


Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©atelim.com 2016
rəhbərliyinə müraciət